07:00 , Jul 13, 2015 |  BC Week In Review  |  Clinical News

AntriaBio preclinical data

AntriaBio said a single subcutaneous dose of 37.5 mg/kg AB101 in rats and a single subcutaneous dose of 10 or 37.5 mg/kg AB101 in dogs led to a maximum insulin concentration (Cmax) of >30 ng/mL...
08:00 , Jan 14, 2013 |  BC Week In Review  |  Company News

AntriaBio, PR Pharma deal

AntriaBio will reverse-merge with public shell company Fits My Style Inc. (OTCQB:FMYYD, Menlo Park, Calif.) in a stock deal. AntriaBio shareholders exchanged all of their shares for an undisclosed number of outstanding shares of...